We are 5,6,7,8-Tetrahydronaphthalene-1-carboxylic acid CAS:4242-18-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Chemical Name:5,6,7,8-Tetrahydronaphthalene-1-carboxylic acid
CAS.NO: 4242-18-6
Synonyms:
1-Naphthoic acid,5,6,7,8-tetrahydro
5,6,7,8-Tetrahydro-1-naphthalenecarboxylicacid
5,6,7,8-Tetrahydro-[1]naphthoesaeure
1-Naphthalenecarboxylic acid,5,6,7,8-tetrahydro
1,2,3,4-tetrahydro-5-naphthoic acid
5,6,7,8-Tetrahydro-1-naphthoic acid
5,6,7,8-Tetrahydronaphthalene-1-carboxylic Acid
5,6,7,8-tetrahydro-1-naphtoic acid
1-Naphthalenecarboxylic acid, 5,6,7,8-tetrahydro-
5,6,7,8-tetrahydronaphthalen-1-carboxylic acid
5,6,7,8-tetrahydronaphthalenecarboxylic acid
Molecular Formula: C11H12O2
Molecular Weight: 176.21200
Physical and Chemical Properties:
Density: 1.184 g / cm3
Boiling point: 336.8ºC at 760 mmHg
Melting point: 148-152ºC
Flash point: 154.2ºC
Refractive index: 1.586
Specification:
Appearance:White or almost white crystalline powder
Purity:≥98%
Loss on drying:≤1.0%
Packing:
25kg cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Palonosetron hydrochloride CAS:135729-61-2
Related News: If an API is not ultrapure, a medicine cannot meet the strict quality criteria so the quality of an API plays a very important role.2417-72-3 Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections.455-86-7 Immediately thereafter, the iLet begins controlling blood-sugar levels automatically, without requiring the user to count carbohydrates, set insulin delivery rates, or deliver bolus insulin for meals or corrections.1-clorododecano CAS:112-52-7 Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.Fate Therapeutics’ iPSC product platform is supported by an intellectual property portfolio of over 250 issued patents and 150 pending patent applications.
Product Name | |
---|---|
Pancreatin Cas:8049-47-6 | View Details |
TRIMETHYLSILOXYSILICATE Cas:56275-01-5 | View Details |
3-Amino-2-chloropyridine | View Details |